- Home
- ICHR
ICHR
Ichor Holdings
as 04-18-2025 1:37pm EST
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | N/A | IPO Year: | 2016 |
| Target Price: | $41.33 | AVG Volume (30 days): | 402.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.84 - $42.70 | Next Earning Date: | 05-05-2025 |
| Revenue: | $849,040,000 | Revenue Growth: | 4.67% |
| Revenue Growth (this year): | 19.66% | Revenue Growth (next year): | 11.71% |
Stock Insider Trading Activity of Ichor Holdings (ICHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ROHRS THOMAS M | ICHR | Director | Feb 14 '25 | Sell | $32.17 | 125,000 | $4,014,842.64 | 94,559 | |
| Titinger Jorge | ICHR | Director | Feb 7 '25 | Sell | $32.04 | 3,000 | $96,120.00 | 9,832 |
Latest Ichor Holdings News
ICHR Breaking Stock News: Dive into ICHR Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
ICHR: Raising target price to $19.00
Argus Research
10 days ago
ICHR: Lowering target price to $18.00
Business Wire
12 days ago
Ichor to Announce First Quarter 2025 Financial Results on May 5th
Argus Research
17 days ago
ICHR: Lowering target price to $23.00
Argus Research
24 days ago
ICHR: Rating increased to a HOLD
Insider Monkey
a month ago
Is Ichor Holdings (ICHR) The High Growth Low Debt Stock to Invest in Now?
Argus Research
a month ago
ICHR: Lowering target price to $23.00
Argus Research
2 months ago
ICHR: Lowering target price to $24.00
Compare ICHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICHR Ichor Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.